Tender detail

Open-house medicine discount agreements for belimumab (ATC L04AG04)

Summary

AOK Bayern is offering non-exclusive, identical, non-negotiable medicine discount agreements covering the active substance belimumab (ATC L04AG04). The agreements may start from 1 January 2027 and end on 31 December 2028; they may be concluded during that period, no later than 3 November 2028. They may be terminated with one month’s notice to the end of a month, and may automatically cease to apply for the relevant period if a nationwide or state-level discount agreement for the same active substance takes effect.

Reference number
33d89fbc-136c-4a49-91f6-7f9f0fcd82c6
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-11-03
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.